Essent Biologics Launches Micronized Bone Matrix

Essent Biologics, a supplier of human-derived cell and scaffold materials, announced availability of its Micronized Bone Matrix (MBM) for 3D bioprinting and tissue engineering applications. Essent Biologics will provide a mineralized allograft bone matrix derived from human ground cortical bone that contains native proteins, such as Collagen Type I, and native elements and minerals, such as calcium and phosphorus.

Essent Biologics’ MBM is provided at a compatible size for extrusion 3D bioprinting, with a ≤300µm particle size, and is recovered and processed without the use of animal products.

“Providing this human scaffolding material provides a ready-made, biologically relevant bioink additive for researchers in the 3D printing world,” said Jeffrey Brown, Executive Vice President of Research & Development at Essent Biologics. “Essent’s MBM, along with our previously launched demineralized ground bone product, Spectral DBM, will support the work of those interested in human bone characterization as well as the burgeoning field of bone tissue engineering.”

Source: Essent Biologics

JAV

Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE